Toripalimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer

NCT05084677 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

96

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer

Interventions

COMBINATION_PRODUCT: Toripalimab Combined With Concurrent Platinum-based Chemoradiotherapy

Sponsor

Tianjin Medical University Cancer Institute and Hospital